Revenue

Metric · Financial Performance

Displaying items 2201-2220 of 22696 in total

Acuity’s Pivot: Smart Spaces Fuel Profit as Lighting Dims

Read full article
Acuity’s Pivot: Smart Spaces Fuel Profit as Lighting Dims

Darden’s Blueprint for Dominance: Brand Strategy and Capital Discipline

Read full article
BriefGlance

KBR Unveils Leaders for $5B Spin-Off, Forging New National Security Giant

Read full article
KBR Unveils Leaders for $5B Spin-Off, Forging New National Security Giant

GFL’s Masterstroke: How a Florida HQ Move Paved the Way to Wall Street

Read full article
GFL’s Masterstroke: How a Florida HQ Move Paved the Way to Wall Street

Thailand's Robotic Leap: AGIBOT and VST ECS Launch Embodied AI Era

Read full article
Thailand's Robotic Leap: AGIBOT and VST ECS Launch Embodied AI Era

NIP Group's Double Game: ESG Gloss and a High-Stakes Bitcoin Bet

Read full article
BriefGlance

The Festival Economy: How Ancient Traditions Fuel Modern Growth in China

Read full article
The Festival Economy: How Ancient Traditions Fuel Modern Growth in China

Beyond the Screen: The Billion-Dollar Bet on Feeling Your Favorite Shows

Read full article
Beyond the Screen: The Billion-Dollar Bet on Feeling Your Favorite Shows

IBA's Brazil Gambit: A €45M Bet on Latin America's Cancer Care Future

Read full article
IBA's Brazil Gambit: A €45M Bet on Latin America's Cancer Care Future

Doncasters’ NYSE Debut: A Titan Forges Its Future in Aerospace & Energy

Read full article
Doncasters’ NYSE Debut: A Titan Forges Its Future in Aerospace & Energy

Dye & Durham Ousts CEO Amid Market Revolt, Installs Board Committee

Read full article
Dye & Durham Ousts CEO Amid Market Revolt, Installs Board Committee

SIR Corp. Serves Up Growth & Innovation Amidst Industry-Wide Strain

Read full article
BriefGlance

New CEO at Alaska Communications: A Fresh Vision for the Final Frontier

Read full article
New CEO at Alaska Communications: A Fresh Vision for the Final Frontier

ARS Pharma's Payer Setback Highlights Innovation's Costly Toll

Read full article
ARS Pharma's Payer Setback Highlights Innovation's Costly Toll

From Red Ink to Dividends: Barnes & Noble Education Rewrites Its Story

Read full article
From Red Ink to Dividends: Barnes & Noble Education Rewrites Its Story

Beyond the Index: Decoding FormFactor’s Ascent to Large-Cap Status

Read full article
Beyond the Index: Decoding FormFactor’s Ascent to Large-Cap Status

Church & Dwight's Q2 Test: Can Portfolio Strength Override Market Headwinds?

Read full article
Church & Dwight's Q2 Test: Can Portfolio Strength Override Market Headwinds?

Friedman’s 54-Year Dividend: A Signal of Steel-Clad Stability?

Read full article
Friedman’s 54-Year Dividend: A Signal of Steel-Clad Stability?

ICF's Q2 Earnings: A Pivotal Moment for Its 2026 Growth Strategy

Read full article
ICF's Q2 Earnings: A Pivotal Moment for Its 2026 Growth Strategy

Ionis's RNA Drug TRYNGOLZA Wins FDA Approval for High Triglycerides

Read full article
Ionis's RNA Drug TRYNGOLZA Wins FDA Approval for High Triglycerides

Related topics in Financial Performance